Documents & Resources
Medicines pricing, impact and pharmaceutical benchmarking
02 April 2008
In Categories:
Nursing
On 1 December 2006, a draft medicine pricing benchmarking methodology was published by the Department of Health on the recommendation of the Pricing Committee.
Val Beaumont, M.Pharm, FPS, Executive Director, Innovative Medicines SA Elsabé Klinck, B.Juris, L.LB, BA Hons, Health Projects Manager, Innovative Medicines SA
On 1 December 2006, a draft medicine pricing benchmarking methodology was published by the Department of Health on the recommendation of the Pricing Committee. Background to international benchmarking The benchmarking of medicines forms part of the Pricing Regulations of 2004, published in terms of the Medicines and Related Substances Act of 1965, as amended. Section 22G of the Act tasked the Pricing Committee with the introduction of a transparent pricing system.
This system included the setting of a Single Exit Price (SEP) and a system of logistics- and dispensing fees. The logistics fees are included in the SEP, so that the basic price patients pay for medicines in the private sector, are exactly the same, irrespective of where such patients are. SEPs were set during the second half of 2004.
Other components of the regulations include:
• The capping of logistics fees
• The setting of dispensing fees for medical practitioners and pharmacies
• The setting of the SEP for new products
• Annual price increases
• International benchmarking
• Publication of unreasonable prices.
Of these, only the setting of the SEP for new products and annual prices increases has been established. Success of current pricing regulation implementation The implementation of the SEP in 2004 yielded a saving of between 19 and 21% over the total market. In addition, there has been price freezes since the publication of the draft SEP-regulations.
The first announcement for price increases (of 5.2% for the years 2005 and 2006) where made in October 2006, which increases became effective, for companies, which notified the Department of Health, early 2007. These savings have also impacted the medical schemes environment. If the so-called “healthcare pie” is re-drawn (figure 1, based on CMS Annual Report 2005-2006) to include the costs relating to the full delivery of healthcare, medicines only constitute 13,45% of the Rand spend in the total medical schemes market. When non-healthcare costs are removed from the pie, the medicines portion is still in line with international benchmarks (if set in terms of the relevant insured populations) (Figure 2).
Related:
FAQ
NEWS
DOCUMENTS
|
Lucas Malambe is Hasa's Executive Officer, Corporate Communications educated at the universities of the North and Witwatersrand. Malambe has a postgraduate qualification in Business Management and Economics from the University of Johannesburg where he is finishing his Masters in Commerce (Business Management).
He is also the editor of the prestigious research-driven publications Health Annals and the monthly Hasa News.
He has seven years experience in public communications having worked for DRUM magazine as a health journalist, sub-editor, and columnist. Lucas also worked for Lifeline Southern Africa interfacing with the organisation's various publics. At this time he contributed regularly to publications such as Business Day's Health Supplement and Mshana as a health correspondent and health-advice columnist respectively.
|
click here for contact details
13 July 2010
The annual Hasa Awards of Excellence are part of the Ministerial Healthcare Awards. This year's theme is Quality is Excellence. The process to find the best of the best in the private hospital industry is nearing its end. The Health Excellence Awards 2010 will take place in November 2010 and the deadline date for submission of entries is 07 October 2010.
15 June 2010
The Children’s Act 38 of 2005 (as amended). How does it affect healthcare?
Several outstanding provisions of the Children’s Act [Act 38 of 2005] have become operational. The relevant Government Gazette has made the date upon which the law became operational as being 01 April 2010.
02 June 2010
HASA LEGALWatch:June01
Update on Sections 55 and 56 of the National Health Act, 2003 relating to the
removal of blood or other tissue, together with section 68 which
permits the Minister of Health to make regulations relating to tissue,
cells, organs, blood, blood products and gametes, has been
promulgated. (In other words, has become law, as of the 17th of May
2010). Download The June 01 LegalWatch:
Click here for doc's
 |
|
The Hospital Association of South Africa is a non-statutory body; the Association will gladly act as a mediator and will investigate an incident on behalf of a patient, or relative.
|
Lodge a Complaint
|
